HC Wainwright & Co. Maintains Buy on Clene, Lowers Price Target to $7
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Clene (NASDAQ:CLNN) but lowers the price target from $15 to $7.
June 21, 2023 | 10:27 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. maintains a Buy rating on Clene (NASDAQ:CLNN) but lowers the price target from $15 to $7.
The news of HC Wainwright & Co. maintaining a Buy rating on Clene is positive for the stock. However, the lowering of the price target from $15 to $7 may create uncertainty among investors, potentially offsetting the positive sentiment. As a result, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100